Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults
Clinical trial NCT05303324 · COMPLETED
Trial details
- NCT number
- NCT05303324
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2019-10-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.